INSIGHTS ON QUALITY ASSURANCE

• CAR-T Cell Therapy For Cancer: The Patient's In The Process

  Autologous cell therapies require absolute process repeatability. Learn how automated cryovial filling protects cell viability and eliminates manual variability.

• Identification Of Conjugation Sites In An Antibody Drug Conjugate

  A streamlined workflow enables confident mapping of lysine-linked conjugation sites in ADCs. See how integrated automation and high-resolution analysis simplify complex characterization challenges.

• How Robotic Isolator Technology Aligns To Annex 1 Principles

  Robotic gloveless isolators provide exceptional automation to eliminate human intervention and reduce contamination risk. Discover how they ensure compliance with the EU Annex 1 guideline to enhance sterility, precision, and monitoring.

• Particle Data Collection And Interpretation For ISO Cleanrooms

  Transition from periodic sampling to continuous monitoring. Learn to establish risk-based alert limits and use N:M trending to maintain a true state of control in critical cleanroom zones.

• Application Of LC-UV/MS Workflows To Increase Efficiency

  7/29/2025

  Discover how LC-UV/MS workflows help overcome analytical challenges in GLP-1 analog development to streamline impurity identification and boost lab efficiency in research.

• Pharmaceutical Bioburden And Microbial Limits Testing

  3/5/2026

  Explore how membrane filtration tools streamline bioburden and microbial enumeration while improving ergonomics and easing routine tasks in fast‑paced pharmaceutical microbiology labs.

• GMP Compliance In Pharmaceutical Manufacturing: Why Product Inspection Matters

  9/17/2026

  Learn how integrating advanced inspection technology—including X-ray systems, metal detectors, and checkweighers—can optimize your compliance strategy and protect product quality.

• Aiming For Success In Early mAb Process Development And Beyond

  7/15/2025

  Developing a monoclonal antibody (mAb) requires strict quality compliance. Building on a strong foundation from the start with a quality by design (QbD) approach is key for success and minimizing variability.

• Why Cloud Migration Is The Key To Business Agility

  5/31/2026

  Discover how transitioning to cloud-native architectures drives business agility in biopharma, reducing infrastructure costs, minimizing downtime, and accelerating time to market for novel therapies.